YM, A., J, R., P, S., G, C., P, K., O, P., . . . RS, M. (2025). Comparative outcomes of HSCT with posttransplant cyclophosphamide in older adults: The impact of donor type. Blood advances, 9(20), 5201. https://doi.org/10.1182/bloodadvances.2025016592
Chicago Style (17th ed.) CitationYM, Aljawai, et al. "Comparative Outcomes of HSCT with Posttransplant Cyclophosphamide in Older Adults: The Impact of Donor Type." Blood Advances 9, no. 20 (2025): 5201. https://doi.org/10.1182/bloodadvances.2025016592.
MLA (9th ed.) CitationYM, Aljawai, et al. "Comparative Outcomes of HSCT with Posttransplant Cyclophosphamide in Older Adults: The Impact of Donor Type." Blood Advances, vol. 9, no. 20, 2025, p. 5201, https://doi.org/10.1182/bloodadvances.2025016592.
Warning: These citations may not always be 100% accurate.
